"No man that does not see visions
will ever realize any high hope
or undertake any high enterprise."

Thomas Woodrow Wilson (1856-1924),
President of the United States of America,
1913-1921

More than 20 years of active commitment of a motivated
and creative producer of laboratory diagnostics.

2016 January
Effective January 1, 2016 Prof. Dr. Tomas Porst­mann retired from his position as mana­ging director at Seramun Diagnostica GmbH. The new managing director is Ms. Renate Fischer, who will be running the company together with Dr. Silvia Porstmann.
The new management team as well as all employees will continue to carefully further develop Seramun Diagnostica GmbH at it's known current location. The needs of our distribution partners as well as end-users continue to have the highest priority.

2014 June
Commissioning of the 400m² large animal-care facility with 1250 m² outdoor enclosure and 60m² quarantine facility on the Seramun premises for the generation of antibodies required by the IVD sector and scientific institutions.

2012 December
On the occasion of its 20th anniversary, Seramun presents under the brand name Seraspot a microtitre plate-based automatable multiplex technology applied in the diagnostics of infectious and autoimmune diseases at the Medica in Dusseldorf.

2011 June
The former unutilized loft was reconstructed to establish further 500 qm of working area and an attractive breakroom for the Seramun staff.

2010 November
Establishment of a clean room for microarray development
Expansion of laboratory area for research and development and quality control investments.

2009 March
Establishment of a molecular biology laboratory (S1) to handle genetically modified organisms

2004 December
Establishment of an L2 laboratory to handle human pathogenic agents

2003 December
Start of the production in the new laboratories with a staff of 16, including two medical doctors, one biologist, one biotechnologist and two chemists

2003 November
Movement to the new residence. Certification of the company's quality management system According to DIN EN ISO 9001:2000 and DIN EN ISO 13485:2003 by German federal licensing authority (TÜV Rheinland)

2001 January - 2003 October
Reconstruction of a former charitable home to modern laboratory and administration facilities (floor space 2000 m²)

1999 November
First presentation at MEDICA

1998 October
Certification of the company's quality management system according to DIN EN ISO 9001 by German federal licensing authority (TÜV Rheinland)

1997 May
General license to produce, store and sell in-vitro diagnostic kits according to German federal pharmaceutical law (AMG), issued by Brandenburg state health authority (Landesamt für Soziales und Versorgung des Landes Brandenburg, Abt. Landesgesundheitsamt)

1995 June
Full range of business activities, following construction of development and production facilities (Laboratory size 200 m²)

1994 April
First immunoassay developments and antibody production (Laboratory size 20 m²)

1992 November
Establishment of the company in Dolgenbrodt, Landkreis Dahme / Spreewald, Brandenburg, Germany, Managing director / main Shareholder is Prof. Dr. med. T. Porstmann

2016: Baton handover to the new management
2016: Baton handover to the new management
2014: This animal-care facility enables Seramun to enhance the service portfolio.
2014: This animal-care facility enables Seramun to enhance the service portfolio.
2011: A modern breakroom, sanitary facilities and new offices
2011: A modern breakroom, sanitary facilities and new offices
2004: modern equipped laboratories Investments: ca. 0.2 Mio EURO
2004: modern equipped laboratories
Investments: ca. 0.2 Mio EURO
2003: Area: 2000 qm, Investments: 2.17 Mio EURO, Own financial contribution: 1.07 Mio EURO
2003: Area: 2000 qm
Investments: 2.17 Mio EURO
Own financial contribution:
1.07 Mio EURO
1994: Area: 80 qm, Investments: ca. 0.25 Mio EURO
1994: Area: 80 qm
Investments: ca. 0.25 Mio EURO
1992: Area: 17 qm, Investments: ca. 25.000 EURO
1992: Area: 17 qm
Investments: ca. 25.000 EURO